vimarsana.com
Home
Live Updates
A Regulator Looks Back On What We Learned From Accelerated S
A Regulator Looks Back On What We Learned From Accelerated S
A Regulator Looks Back On What We Learned From Accelerated SARS-CoV-2 Neutralizing mAbs Development
Prior knowledge, platforms, parallel backup programs, and strategic timing all come into play when rapidly scaling up a mAbs development program in...
Related Keywords
United States ,
Salisbury ,
Mashonaland East ,
Zimbabwe ,
Mexico ,
Maria Teresa Gutierrez Lugo ,
University Of Arizona ,
Abs And Those In Development ,
Public Health Emergency ,
Health Services ,
National Autonomous University Of Mexico ,
Office Of Biotechnology Products ,
Development Program ,
Department Of Human ,
Biotechnology Products ,
Monoclonal Antibody Products ,
Human Use ,
That Leverage Experience From Licensed ,
Industry And Regulators To Collaborate ,
Products Targeting ,
Including Addressing ,
Emerging Variants ,
Health Emergency ,
Drug Substances ,
Using Analytical Platform Technologies ,
Support Accelerated Product Development ,
Concept Review ,
Pharmaceutical Science ,
Teresa Gutierrez Lugo ,
Emergency Use Authorization ,
National Autonomous University ,